欧盟法规
ECHA物质C&L通报上下游产品
CAS号13736-22-6 苯甲醛-4-磺酸钠 | CAS号3240-35-5 4-甲酰基苯磺酰胺 | CAS号816450-54-1 N-(4-chlorophen... | CAS号88654-54-0 4-甲酰基苯-1-磺酰氟 | CAS号920536-28-3 4-formyl-N-[4-(...合成工艺路线路线简述
- 13736-22-6 = 85822-16-8
反应条件:1.1 Reagents: Thionyl Chloride Catalysts: Dimethylformamide; 2 Min,Rt; 3 Min,Rt -> Reflux
标题:An Exploration Of Chemical Properties Required For Cooperative Stabilization Of The 14-3-3 Interaction With Nf-Kb-Utilizing A Reversible Covalent Tethering Approach
作者:Wolter,Madita; Et Al
参考文献:Journal Of Medicinal Chemistry 日期:2021 卷标:64(12) 页码:8423-8436]
91358-96-2 + 127-65-1 = 85822-16-8
反应条件:1.1 Reagents: Chlorosuccinimide Solvents: Acetonitrile,Water; Rt1.2 Solvents: Acetonitrile; 2 Min,Rt; 15 Min,35 °C
标题:Aminoxidation Of Arenethiols To N-Chloro-N-Sulfonyl Sulfinamides
作者:Yang,Zhanhui; Et Al
参考文献:Journal Of Organic Chemistry 日期:2016 卷标:81(7) 页码:3051-3057
📜Sodium 4-Formylbenzenesulfonate置于氯化亚砜体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应 0.25H,反应生成 4-甲酰基苯磺酰氯
参考文献:14-3-3 与 Nf-Kb 相互作用的协同稳定所需化学性质的探索--利用可逆共价束缚方法
标题:14-3-3 与 Nf-Kb 相互作用的协同稳定所需化学性质的探索--利用可逆共价束缚方法
摘要:蛋白质-蛋白质调节已成为一种行之有效的药物发现方法.虽然在开发蛋白质-蛋白质相互作用 (Ppi) 抑制剂方面取得了重大进展,但 Ppi 稳定的正交方法缺乏用于药物设计的既定方法.在这里,我们报告了可逆共价 Ppi 稳定剂的系统性"自下而上"开发.使用亚胺键将稳定剂锚定在 14-3-3/p65 复合物的界面上,从而产生一种分子胶,使复合物的稳定性提高 81 倍.利用蛋白质晶体学和生物物理分析,我们解开了稳定剂的化学性质如何转化为三元 14-3-3/p65/分子胶复合物的结构变化.此外,我们探索了这如何导致复杂的高度协同性和增加的稳定性.
DOI:10.1021/acs.Jmedchem.1C00401
专利信息
专利号:US-2008194629-A1
优先权日:2005-05-03
标题 :3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors
发明人:BAESCHLIN DANIEL KASPAR; BREITENSTEIN WERNER; EHRHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; RUDISSER SIMON; VANGREVELINGHE ERIC; IRIE OSAMU; UMEMURA ICHIRO; SUZUKI MASAKI; MOGI MUNETO; KANAZAWA TAKANORI; YOKOKAWA FUMIAKI; NIHONYANAGI ATSUKO
权利人:BAESCHLIN DANIEL KASPAR; BREITENSTEIN WERNER; EHRHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; RUDISSER SIMON; VANGREVELINGHE ERIC; IRIE OSAMU; UMEMURA ICHIRO; SUZUKI MASAKI; MOGI MUNETO; KANAZAWA TAKANORI; YOKOKAWA FUMIAKI; NIHONYANAGI ATSUKO
摘要:The invention relates to 3,5-piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-piperidine compound, and/or a method of treatment comprising administering a 3,5-piperidine compound, a method for the manufacture of a 3,5-piperidine compound, and novel intermediates and partial steps for their synthesis. Especially, the 3,5-piperidine compounds have the formula I, wherein the symbols have the meanings described in the specification.